Utility of imaging for nutritional intervention studies in Alzheimer's disease

European Journal of Pharmacology

Volumn 668, Issue SUPPL. 1, 2011, Pages

  De Wilde, Martijn C ^a   Kamphuis, Patrick J G H ^a,b   Sijben, John W C ^a   Scheltens, Phillip ^c  

^a DANONE RESEARCH   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Biomarkers; Medical food; Neuroimaging; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN[1-42]; ANTIOXIDANT; BETA CAROTENE; BIOLOGICAL MARKER; CARBOHYDRATE; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINE ALFOSCERATE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FLUORODEOXYGLUCOSE F 18; FOLIC ACID; FORTASYN; GLYCINE; ICOSAPENTAENOIC ACID; MEMANTINE; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PLACEBO; PYRIDOXINE; SELEGILINE; SOUVENAID; SR 3; SUPRADYN; TAU PROTEIN; THIAMINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN B GROUP; XANTHOPHYLL;

ALZHEIMER DISEASE; CONFERENCE PAPER; DEMENTIA; DIET THERAPY; DIFFUSION TENSOR IMAGING; ELECTROENCEPHALOGRAPHY; HUMAN; INTERVENTION STUDY; MAGNETOENCEPHALOGRAPHY; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; SYNAPTIC TRANSMISSION; THERAPY EFFECT;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL MARKERS; FUNCTIONAL NEUROIMAGING; HUMANS; NEUROIMAGING;

EID: 80054985856     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.07.011     Document Type: Conference Paper

References (131)

1. ADI World Alzheimer report 2010: The global economic impact of dementia Accessed 25 May 2011 at http://www.alz.co.uk/research/files/ WorldAlzheimerReport2010ExecutiveSummary.pdf 2010
2. P.S. Aisen, L.S. Schneider, M. Sano, R. Diaz-Arrastia, C.H. Van Dyck, M.F. Weiner, T. Bottiglieri, S. Jin, K.T. Stokes, R.G. Thomas, and L.J. Thal High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial JAMA 300 2008 1774 1783
3. N. Andreasen, C. Hesse, P. Davidsson, L. Minthon, A. Wallin, B. Winblad, H. Vanderstichele, E. Vanmechelen, and K. Blennow Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease Arch. Neurol. 56 1999 673 680 (Pubitemid 29266465)
4. V.A. Andreeva, E. Kesse-Guyot, P. Barberger-Gateau, L. Fezeu, S. Hercberg, and P. Galan Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial Am. J. Clin. Nutr. 2011
5. L.I. Arwert, J.B. Deijen, and M.L. Drent Effects of an oral mixture containing glycine, glutamine and niacin on memory, GH and IGF-I secretion in middle-aged and elderly subjects Nutr. Neurosci. 6 2003 269 275 (Pubitemid 37361908)
6. D. Attwell, and C. Iadecola The neural basis of functional brain imaging signals Trends Neurosci. 25 2002 621 625 (Pubitemid 35356509)
7. T. Best, E. Kemps, and J. Bryan Saccharide effects on cognition and well-being in middle-aged adults: a randomized controlled trial Dev. Neuropsychol. 35 2010 66 80
8. I. Blasko, K. Jellinger, G. Kemmler, W. Krampla, S. Jungwirth, I. Wichart, K.H. Tragl, and P. Fischer Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine Neurobiol. Aging 29 2008 1 11 (Pubitemid 350102708)
9. J.P. Blass, P. Gleason, D. Brush, P. DiPonte, and H. Thaler Thiamine and Alzheimer's disease. A pilot study Arch. Neurol. 1988 833 835
10. K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat. Rev. Neurol. 6 2010 131 144
11. J.M. Bourre Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients J. Nutr. Health Aging 10 2006 377 385 (Pubitemid 44845348)
12. J.M. Bourre Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients J. Nutr. Health Aging 10 2006 386 399 (Pubitemid 44845349)
13. R.P. Brenner, C.F. Reynolds III, and R.F. Ulrich Diagnostic efficacy of computerized spectral versus visual EEG analysis in elderly normal, demented and depressed subjects Electroencephalogr. Clin. Neurophysiol. 69 1988 110 117 (Pubitemid 18024751)
14. A.M. Brickman, S.A. Small, and A. Fleisher Pinpointing synaptic loss caused by Alzheimer's disease with fMRI Behav. Neurol. 21 2009 93 100
15. J. Bryan, E. Calvaresi, and D. Hughes Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages J. Nutr. 132 2002 1345 1356 (Pubitemid 34606475)
16. K. Buerger, M. Ewers, T. Pirttila, R. Zinkowski, I. Alafuzoff, S.J. Teipel, J. DeBernardis, D. Kerkman, C. McCulloch, H. Soininen, and H. Hampel CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease Brain 129 2006 3035 3041 (Pubitemid 44684523)
17. T. Cenacchi, T. Bertoldin, C. Farina, M.G. Fiori, and G. Crepaldi Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration Aging (Milano) 5 1993 123 133 (Pubitemid 23148315)
18. E. Cetin, E.C. Top, G. Sahin, Y.G. Ozkaya, H. Aydin, and F. Toraman Effect of vitamin E supplementation with exercise on cognitive functions and total antioxidant capacity in older people J. Nutr. Health Aging 14 2010 763 769
19. A. Chan, R. Remington, E. Kotyla, A. Lepore, J. Zemianek, and T.B. Shea A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia J. Nutr. Health Aging 14 2010 224 230
20. R.K. Chandra Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects Nutrition 17 2001 709 712 (Pubitemid 32821143)
21. C.-C. Chiu, K.-P. Su, T.-C. Cheng, H.-C. Liu, C.-J. Chang, E. Dewey Michael, R. Stewart, and S.-Y. Huang The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study Prog. Neuropsychopharmacol. Biol. Psychiatry 32 2008 1538 1544
22. M. Citron Alzheimer's disease: treatments in discovery and development Nat. Neurosci. 5 Suppl 2002 1055 1057 (Pubitemid 35247198)
23. R. Clarke, G. Harrison, and S. Richards Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia J. Intern. Med. 254 2003 67 75 (Pubitemid 36819131)
24. P.J. Connelly, N.P. Prentice, G. Cousland, and J. Bonham A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease Int. J. Geriatr. Psychiatry 23 2008 155 160 (Pubitemid 351308495)
25. U. Cornelli Treatment of Alzheimer's disease with a cholinesterase inhibitor combined with antioxidants Neurodegener Dis 7 2010 193 202
26. F.M. Corrigan, A. Van Rhijn, and D.F. Horrobin Essential fatty acids in Alzheimer's disease Ann. N. Y. Acad. Sci. 640 1991 250 252
27. T.H. Crook, J. Tinklenberg, J. Yesavage, W. Petrie, M.G. Nunzi, and D.C. Massari Effects of phosphatidylserine in age-associated memory impairment Neurology 41 1991 644 649
28. T. Crook, W. Petrie, C. Wells, and D.C. Massari Effects of phosphatidylserine in Alzheimer's disease Psychopharmacol. Bull. 28 1992 61 66
29. A.D. Dangour, E. Allen, D. Elbourne, N. Fasey, A.E. Fletcher, P. Hardy, G.E. Holder, R. Knight, L. Letley, M. Richards, and R. Uauy Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial Am. J. Clin. Nutr. 91 2010 1725 1732
30. M. De Jesus Moreno Moreno Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial Clin. Ther. 25 2003 178 193
31. J.B. Deijen, E.J. van der Beek, J.F. Orlebeke, and H. van den Berg Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort Psychopharmacology (Berl) 109 1992 489 496
32. P.J. Delwaide, A.M. Gyselynck-Mambourg, A. Hurlet, and M. Ylieff Double-blind randomized controlled study of phosphatidylserine in senile demented patients Acta Neurol. Scand. 73 1986 136 140 (Pubitemid 16124005)
33. B.S. Diniz, J.A. Pinto Junior, and O.V. Forlenza Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature World J. Biol. Psychiatry 9 2008 172 182
34. J. Durga, M.P. van Boxtel, E.G. Schouten, F.J. Kok, J. Jolles, M.B. Katan, and P. Verhoef Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial Lancet 369 2007 208 216 (Pubitemid 46107683)
35. M.W. Dysken, P. Fovall, C.M. Harris, J.M. Davis, and A. Noronha Lecithin administration in Alzheimer dementia Neurology 32 1982 1203 1204
36. R.R. Engel, W. Satzger, W. Gunther, N. Kathmann, D. Bove, S. Gerke, U. Munch, and H. Hippius Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type Eur. Neuropsychopharmacol. 2 1992 149 155
37. M.J. Engelhart, M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, A. Hofman, J.C. Witteman, and M.M. Breteler Dietary intake of antioxidants and risk of Alzheimer disease JAMA 287 2002 3223 3229 (Pubitemid 34686103)
38. P. Etienne, D. Dastoor, S. Gauthier, R. Ludwick, and B. Collier Alzheimer disease: lack of effect of lecithin treatment for 3 months Neurology 31 1981 1552 1554 (Pubitemid 12242012)
39. S.J. Eussen, L.C. de Groot, L.W. Joosten, R.J. Bloo, R. Clarke, P.M. Ueland, J. Schneede, H.J. Blom, W.H. Hoefnagels, and W.A. van Staveren Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial Am. J. Clin. Nutr. 84 2006 361 370 (Pubitemid 44699146)
40. M. Fioravanti, E. Ferrario, M. Massaia, G. Cappa, G. Rivolta, E. Grossi, and A.E. Buckley Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits Arch. Gerontol. Geriatr. 26 1998 1 13 (Pubitemid 27511030)
41. M.J. Firbank, R.M. Harrison, and J.T. O'Brien A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease Dement. Geriatr. Cogn. Disord. 14 2002 64 76 (Pubitemid 36152947)
42. M. Fisman, H. Merskey, E. Helmes, J. McCready, E.H. Colhoun, and B.J. Rylett Double blind study of lecithin in patients with Alzheimer's disease Can. J. Psychiatry 26 1981 426 428 (Pubitemid 11029919)
43. A.S. Fleisher, M. Donohue, K. Chen, J.B. Brewer, and P.S. Aisen Applications of neuroimaging to disease-modification trials in Alzheimer's disease Alzheimer's Disease Neuroimaging, I Behav. Neurol. 21 2009 129 136
44. S.V. Frankfort, L.R. Tulner, J.P. van Campen, M.M. Verbeek, R.W. Jansen, and J.H. Beijnen Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature Curr. Clin. Pharmacol. 3 2008 123 131
45. L. Fratiglioni, A. Ahlbom, M. Viitanen, and B. Winblad Risk factors for late-onset Alzheimer's disease: a population-based, case-control study Ann. Neurol. 33 1993 258 266 (Pubitemid 23081156)
46. D.B. Freir, R. Fedriani, D. Scully, I.M. Smith, D.J. Selkoe, D.M. Walsh, and C.M. Regan Abeta oligomers inhibit synapse remodelling necessary for memory consolidation Neurobiol. Aging 2010
47. C. Freitas, J. Perez, M. Knobel, J.M. Tormos, L. Oberman, M. Eldaief, S. Bashir, M. Vernet, C. Pena-Gomez, and A. Pascual-Leone Changes in cortical plasticity across the lifespan Front Aging Neurosci. 3 2011 5
48. Y. Freund-Levi, M. Eriksdotter-Jonhagen, T. Cederholm, H. Basun, G. Faxen-Irving, A. Garlind, I. Vedin, B. Vessby, L.-O. Wahlund, and J. Palmblad Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial Arch. Neurol. 63 2006 1402 1408 (Pubitemid 44547551)
49. F. Grodstein, J.H. Kang, R.J. Glynn, N.R. Cook, and J.M. Gaziano A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II Arch. Intern. Med. 167 2007 2184 2190 (Pubitemid 350106737)
50. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat. Rev. Mol. Cell Biol. 8 2007 101 112 (Pubitemid 46432529)
51. C.F. Haskell, B. Robertson, E. Jones, J. Forster, R. Jones, A. Wilde, S. Maggini, and D.O. Kennedy Effects of a multi-vitamin/mineral supplement on cognitive function and fatigue during extended multi-tasking Hum. Psychopharmacol. 25 2010 448 461
52. D. Hill Neuroimaging to assess safety and efficacy of AD therapies Expert Opin. Investig. Drugs 19 2010 23 26
53. S. Holguin, J. Martinez, C. Chow, and R.J. Wurtman Dietary uridine enhances the improvement in learning and memory produced by administering DHA plus choline to gerbils FASEB J. 22 2008 3938 3946
54. J. Hort, J.T. O'Brien, G. Gainotti, T. Pirttila, B.O. Popescu, I. Rektorova, S. Sorbi, and P. Scheltens EFNS guidelines for the diagnosis and management of Alzheimer's disease Eur. J. Neurol. 17 2010 1236 1248
55. W.T. Hu, A. Chen-Plotkin, S.E. Arnold, M. Grossman, C.M. Clark, L.M. Shaw, L. McCluskey, L. Elman, J. Karlawish, H.I. Hurtig, A. Siderowf, V.M. Lee, H. Soares, and J.Q. Trojanowski Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease Acta Neuropathol. 120 2010 385 399
56. W.T. Hu, A. Chen-Plotkin, S.E. Arnold, M. Grossman, C.M. Clark, L.M. Shaw, E. Pickering, M. Kuhn, Y. Chen, L. McCluskey, L. Elman, J. Karlawish, H.I. Hurtig, A. Siderowf, V.M. Lee, H. Soares, and J.Q. Trojanowski Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment Acta Neuropathol. 119 2010 669 678
57. W.J. Jagust, D. Bandy, K. Chen, N.L. Foster, S.M. Landau, C.A. Mathis, J.C. Price, E.M. Reiman, D. Skovronsky, and R.A. Koeppe The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core Alzheimers Dement. 6 2010 221 229
58. J. Jeong EEG dynamics in patients with Alzheimer's disease Clin. Neurophysiol. 115 2004 1490 1505 (Pubitemid 38760295)
59. F. Jessen, O. Gür, W. Block, G. Ende, L. Frölich, T. Hammen, J. Wiltfang, T. Kucinski, H. Jahn, R. Heun, W. Maier, H. Kölsch, J. Kornhuber, and F. Träber A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI Neurology 72 2009 1735 1740
60. E.J. Johnson, K. McDonald, S.M. Caldarella, H.Y. Chung, A.M. Troen, and D.M. Snodderly Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women Nutr. Neurosci. 11 2008 75 83
61. R.S. Jones, and A.D. Waldman 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia Neurol. Res. 26 2004 488 495 (Pubitemid 38879230)
62. B.L. Jorissen, F. Brouns, M.P. Van Boxtel, R.W. Ponds, F.R. Verhey, J. Jolles, and W.J. Riedel The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment Nutr. Neurosci. 4 2001 121 134 (Pubitemid 34071732)
63. J.H. Kang, N. Cook, J. Manson, J.E. Buring, and F. Grodstein A randomized trial of vitamin E supplementation and cognitive function in women Arch. Intern. Med. 166 2006 2462 2468 (Pubitemid 44913230)
64. A. Kato-Kataoka, M. Sakai, R. Ebina, C. Nonaka, T. Asano, and T. Miyamori Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints J. Clin. Biochem. Nutr. 47 2010 246 255
65. D.O. Kennedy, R. Veasey, A. Watson, F. Dodd, E. Jones, S. Maggini, and C.F. Haskell Effects of high-dose B vitamin complex with vitamin C and minerals on subjective mood and performance in healthy males Psychopharmacology (Berl) 211 2010 55 68
66. T. Kwok, J. Lee, C.B. Law, P.C. Pan, C.Y. Yung, K.C. Choi, and L.C. Lam A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people Clin. Nutr. 30 2011 297 302
67. C. Lewerin, M. Matousek, G. Steen, B. Johansson, B. Steen, and H. Nilsson-Ehle Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study Am. J. Clin. Nutr. 81 2005 1155 1162 (Pubitemid 41724959)
68. A. Little Evaluating treatments for dementia: lessons from the Maudsley lecithin trial Int. J. Geriatr. Psychiatry 11 1996 293 304 (Pubitemid 26141182)
69. A. Little, R. Levy, P. Chuaqui-Kidd, and D. Hand A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease J. Neurol. Neurosurg. Psychiatry 48 1985 736 742 (Pubitemid 15005973)
70. A. Lloret, M.-C. Badia, J. Mora Nancy, V. Pallardo Federico, M.-D. Alonso, and J. Vina Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental J. Alzheimers Dis. 17 2009 143 149
71. D. Malonek, and A. Grinvald Interactions between electrical activity and cortical microcirculation revealed by imaging spectroscopy: implications for functional brain mapping Science 272 1996 551 554 (Pubitemid 26138199)
72. M. Manders, L.C. De Groot, W.H. Hoefnagels, R.A. Dhonukshe-Rutten, W. Wouters-Wesseling, A.J. Mulders, and W.A. Van Staveren The effect of a nutrient dense drink on mental and physical function in institutionalized elderly people J. Nutr. Health Aging 13 2009 760 767
73. N. Mattsson, K. Blennow, and H. Zetterberg CSF biomarkers: pinpointing Alzheimer pathogenesis Ann. N. Y. Acad. Sci. 1180 2009 28 35
74. J.A. McMahon, T.J. Green, C.M. Skeaff, R.G. Knight, J.I. Mann, and S.M. Williams A controlled trial of homocysteine lowering and cognitive performance N. Engl. J. Med. 354 2006 2764 2772 (Pubitemid 43974194)
75. G. McNeill, A. Avenell, M.K. Campbell, J.A. Cook, P.C. Hannaford, M.M. Kilonzo, A.C. Milne, C.R. Ramsay, D.G. Seymour, A.I. Stephen, and L.D. Vale Effect of multivitamin and multimineral supplementation on cognitive function in men and women aged 65 years and over: a randomised controlled trial Nutr. J. 6 2007 10
76. K. Meador, D. Loring, M. Nichols, E. Zamrini, M. Rivner, H. Posas, E. Thompson, and E. Moore Preliminary findings of high-dose thiamine in dementia of Alzheimer's type J. Geriatr. Psychiatry Neurol. 6 1993 222 229 (Pubitemid 23302143)
77. R. Mielke, J. Kessler, B. Szelies, K. Herholz, K. Wienhard, and W.D. Heiss Normal and pathological aging - findings of positron-emission-tomography J. Neural Transm. 105 1998 821 837 (Pubitemid 28539832)
78. L. Minati, M. Grisoli, and M.G. Bruzzone MR spectroscopy, functional MRI, and diffusion-tensor imaging in the aging brain: a conceptual review J. Geriatr. Psychiatry Neurol. 20 2007 3 21 (Pubitemid 46233614)
79. A.J. Mitchell CSF phosphorylated tau in the diagnosis and prognosis of mild cognitive impairment and Alzheimer's disease: a meta-analysis of 51 studies J. Neurol. Neurosurg. Psychiatry 80 2009 966 975
80. M. Moonis, J.M. Swearer, M.P. Dayaw, P. St George-Hyslop, E. Rogaeva, T. Kawarai, and D.A. Pollen Familial Alzheimer disease: decreases in CSF Abeta42 levels precede cognitive decline Neurology 65 2005 323 325 (Pubitemid 41022387)
81. J.M. Morillas-Ruiz, J.M. Rubio-Perez, M.D. Albaladejo, P. Zafrilla, S. Parra, and M.L. Vidal-Guevara Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients J. Neurol. Sci. 299 2010 175 178
82. M.C. Morris The role of nutrition in Alzheimer's disease: epidemiological evidence Eur. J. Neurol. 16 Suppl 1 2009 1 7
83. M.C. Morris, D.A. Evans, J.L. Bienias, C.C. Tangney, D.A. Bennett, N. Aggarwal, J. Schneider, and R.S. Wilson Dietary fats and the risk of incident Alzheimer disease Arch. Neurol. 60 2003 194 200 (Pubitemid 36193962)
84. L. Mosconi, A. Pupi, and M.J. De Leon Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease Ann. N. Y. Acad. Sci. 1147 2008 180 195
85. C. Mulder, P. Scheltens, F. Barkhof, C. Gundy, R.A. Verstraeten, and F.E. de Leeuw Low vitamin B6 levels are associated with white matter lesions in Alzheimer's disease J. Am. Geriatr. Soc. 53 2005 1073 1074 (Pubitemid 41647611)
86. K.A. Nolan, R.S. Black, K.F. Sheu, J. Langberg, and J.P. Blass A trial of thiamine in Alzheimer's disease Arch. Neurol. 48 1991 81 83
87. G. Palmieri, R. Palmieri, M.R. Inzoli, G. Lombardi, C. Sottini, B. Tavolato, and B. Giometto Double-blind controlled trial of phosphatidylserine in patients with senile mental deterioration Clin. Trials J. 24 1987 73 83 (Pubitemid 17074085)
88. C. Qiu, M. Kivipelto, and E. von Strauss Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention Dialogues Clin. Neurosci. 11 2009 111 128
89. J.F. Quinn, R. Raman, R.G. Thomas, K. Yurko-Mauro, E.B. Nelson, C. Van Dyck, J.E. Galvin, J. Emond, C.R. Jack Jr., M. Weiner, L. Shinto, and P.S. Aisen Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial JAMA 304 2010 1903 1911
90. R. Reddy, and M.S. Keshavan Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia Prostaglandins Leukot. Essent. Fatty Acids 69 2003 401 405 (Pubitemid 37464049)
91. R. Remington, A. Chan, J. Paskavitz, and B. Shea Thomas Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study Am. J. Alzheimers Dis. Other Demen. 24 2009 27 33
92. P. Rinaldi, M.C. Polidori, A. Metastasio, E. Mariani, P. Mattioli, A. Cherubini, M. Catani, R. Cecchetti, U. Senin, and P. Mecocci Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease Neurobiol. Aging 24 2003 915 919 (Pubitemid 36962976)
93. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider, and L.J. Thal A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study N. Engl. J. Med. 336 1997 1216 1222 (Pubitemid 27183651)
94. N. Scarmeas, A. Luchsinger Jose, Y. Stern, Y. Gu, J. He, C. Decarli, T. Brown, and M. Brickman Adam Mediterranean diet and magnetic resonance imaging-assessed cerebrovascular disease Ann. Neurol. 69 2011 257 268
95. S.W. Scheff, and D.A. Price Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus J. Alzheimers Dis. 9 2006 101 115 (Pubitemid 44253303)
96. P. Scheltens, P.J.G.H. Kamphuis, F.R.J. Verhey, M.G.M. Olde Rikkert, R.J. Wurtman, D. Wilkinson, J.W.R. Twisk, and A. Kurz Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial Alzheimers Dement. 6 2010 1 10.e11
97. M.L. Selley A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease Neurobiol. Aging 28 2007 1834 1839 (Pubitemid 47542535)
98. S. Seshadri, D.A. Drachman, and C.F. Lippa Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know Arch. Neurol. 52 1995 1074 1079
99. G.M. Shankar, B.L. Bloodgood, M. Townsend, D.M. Walsh, D.J. Selkoe, and B.L. Sabatini Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway J. Neurosci. 27 2007 2866 2875 (Pubitemid 46438992)
100. G.M. Shankar, S. Li, T.H. Mehta, A. Garcia-Munoz, N.E. Shepardson, I. Smith, F.M. Brett, M.A. Farrell, M.J. Rowan, C.A. Lemere, C.M. Regan, D.M. Walsh, B.L. Sabatini, and D.J. Selkoe Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory Nat. Med. 14 2008 837 842
101. L.M. Shaw, M. Korecka, C.M. Clark, V.M. Lee, and J.Q. Trojanowski Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics Nat. Rev. Drug Discov. 6 2007 295 303 (Pubitemid 46505880)
102. M. Shoji, E. Matsubara, M. Kanai, M. Watanabe, T. Nakamura, Y. Tomidokoro, M. Shizuka, K. Wakabayashi, Y. Igeta, Y. Ikeda, K. Mizushima, M. Amari, K. Ishiguro, T. Kawarabayashi, Y. Harigaya, K. Okamoto, and S. Hirai Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease J. Neurol. Sci. 158 1998 134 140 (Pubitemid 28342076)
103. A.D. Smith, S.M. Smith, C.A. de Jager, P. Whitbread, C. Johnston, G. Agacinski, A. Oulhaj, K.M. Bradley, R. Jacoby, and H. Refsum Homocysteine-lowering by b vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial PLoS One 5 2010 1 10
104. L.L. Smits, M. Liedorp, T. Koene, I.E. Roos-Reuling, A.W. Lemstra, P. Scheltens, C.J. Stam, and W.M. van der Flier EEG abnormalities are associated with different cognitive profiles in Alzheimer's disease Dement. Geriatr. Cogn. Disord. 31 2011 1 6
105. L. Sokoloff Relation between physiological function and energy metabolism in the central nervous system J. Neurochem. 29 1977 13 26 (Pubitemid 8150483)
106. B.R. Sommer, A.L. Hoff, and M. Costa Folic acid supplementation in dementia: a preliminary report J. Geriatr. Psychiatry Neurol. 16 2003 156 159 (Pubitemid 37409025)
107. C. Sorg, V. Riedl, R. Perneczky, A. Kurz, and A.M. Wohlschläger Impact of Alzheimer's disease on the functional connectivity of spontaneous brain activity Curr. Alzheimer Res. 6 2009 541 553
108. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, A.M. Fagan, T. Iwatsubo, C.R. Jack, J. Kaye, T.J. Montine, D.C. Park, E.M. Reiman, C.C. Rowe, E. Siemers, Y. Stern, K. Yaffe, M.C. Carrillo, B. Thies, M. Morrison-Bogorad, M.V. Wagster, and C.H. Phelps Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association workgroup Alzheimers Dement. 2011
109. C.J. Stam Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders J. Neurol. Sci. 289 2010 128 134
110. W.K. Summers, R.L. Martin, M. Cunningham, V.L. DeBoynton, and G.M. Marsh Complex antioxidant blend improves memory in community-dwelling seniors J. Alzheimers Dis. 19 2010 429 439
111. Y. Sun, C.-J. Lu, K.-L. Chien, S.-T. Chen, and R.-C. Chen Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients Clin. Ther. 29 2007 2204 2214 (Pubitemid 350138567)
112. A. Tamaoka, N. Sawamura, T. Fukushima, S. Shoji, E. Matsubara, M. Shoji, S. Hirai, Y. Furiya, R. Endoh, and H. Mori Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease J. Neurol. Sci. 148 1997 41 45 (Pubitemid 27149523)
113. M.C. Tartaglia Neuroimaging in dementia Neurotherapeutics 8 2011 82 92
114. R.D. Terry Alzheimer's disease and the aging brain J. Geriatr. Psychiatry Neurol. 19 2006 125 128 (Pubitemid 44154851)
115. R.D. Terry, and R. Katzman Life span and synapses: will there be a primary senile dementia? Neurobiol. Aging 22 2001 347 348 discussion 353-344 (Pubitemid 32510903)
116. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 30 1991 572 580
117. V. Vakhapova, T. Cohen, Y. Richter, Y. Herzog, and A.D. Korczyn Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial Dement. Geriatr. Cogn. Disord. 29 2010 467 474
118. O. van de Rest, J.M. Geleijnse, F.J. Kok, W.A. van Staveren, W.H. Hoefnagels, A.T. Beekman, and L.C. de Groot Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial Am. J. Clin. Nutr. 88 2008 706 713
119. A.C. van Harten, M.I. Kester, P.J. Visser, M.A. Blankenstein, Y.A. Pijnenburg, W.M. van der Flier, and P. Scheltens Tau and p-tau as CSF biomarkers in dementia: a meta-analysis Clin. Chem. Lab. Med. 49 2011 353 366
120. J.G. van Uffelen, M.J. Chinapaw, W. van Mechelen, and M. Hopman-Rock Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial Br. J. Sports Med. 42 2008 344 351 (Pubitemid 351702680)
121. E. von Strauss, M. Viitanen, D. De Ronchi, B. Winblad, and L. Fratiglioni Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians Arch. Neurol. 56 1999 587 592 (Pubitemid 29218154)
122. G.A. Vroulis, R.C. Smith, S. Brinkman, J. Schoolar, and J. Gordon The effects of lecithin on memory in patients with senile dementia of the Alzheimer's type [proceedings] Psychopharmacol. Bull. 17 1981 127 128 (Pubitemid 11180493)
123. G. Vroulis, R.C. Smith, J.C. Schoolar, G. Dahlen, E. Katz, and C.H. Misra Reduction of cholesterol risk factors by lecithin in patients with Alzheimer's disease Am. J. Psychiatry 139 1982 1633 1634 (Pubitemid 13204474)
124. L. Wang, M.A. Albrecht, and R.J. Wurtman Dietary supplementation with uridine-5′-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat Brain Res. 1133 2007 42 48 (Pubitemid 46123254)
125. D.A. Wolk, and W. Klunk Update on amyloid imaging: from healthy aging to Alzheimer's disease Curr. Neurol. Neurosci. Rep. 9 2009 345 352
126. M. Wolters, M. Hickstein, A. Flintermann, U. Tewes, and A. Hahn Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation Prev. Med. 41 2005 253 259 (Pubitemid 40755087)
127. R.J. Wurtman, I.H. Ulus, M. Cansev, C.J. Watkins, L. Wang, and G. Marzloff Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally Brain Res. 1088 2006 83 92 (Pubitemid 43729416)
128. R.J. Wurtman, M. Cansev, T. Sakamoto, and I.H. Ulus Use of phosphatide precursors to promote synaptogenesis Annu. Rev. Nutr. 29 2009 59 87
129. S. Yehuda, S. Rabinovtz, R.L. Carasso, and D.I. Mostofsky Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life Int. J. Neurosci. 87 1996 141 149
130. K. Yurko-Mauro, D. McCarthy, D. Rom, E.B. Nelson, A.S. Ryan, A. Blackwell, N. Salem Jr., and M. Stedman Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline Alzheimers Dement. 6 2010 456 464
131. E. Zamrini, F. Maestu, E. Pekkonen, M. Funke, J. Makela, M. Riley, R. Bajo, G. Sudre, A. Fernandez, N. Castellanos, F. Del Pozo, C.J. Stam, B.W. van Dijk, A. Bagic, and J.T. Becker Magnetoencephalography as a putative biomarker for Alzheimer's disease Int. J. Alzheimers Dis. 2011 2011 280289